Dated : 20th June, 2005
The National Pharmaceutical Pricing Authority (NPPA) has fixed / revised the prices of scheduled bulk drugs Ranitidine Hcl, Nalidixic Acid, Erythromycin & its Derivatives Naproxen / Naproxen Sodium and Norfloxacin under the provisions of DPCO, 1995.
The revised notified prices shall become effective within 15 days from the date of notification in the Official Gazette. All formulators utilizing these drugs in their scheduled formulations are advised to follow the provisions of DPCO, 1995.
Copy of Explanatory Note
For Copies of Notifications please click the following :
| Sl. No. | Name of the Bulk Drug | S.O. No./ Date |
|---|---|---|
| (i) | Ranitidine Hydrochloride | 842(E) / 15th June, 2005 |
| (ii) | Nalidixic Acid | 843(E) / 15th June, 2005 |
| (iii) | Erythromycin Estolate/Base/Stearate/Ethyl Succinate/Propionate | 844(E) / 15th June, 2005 |
| (iv) | Naproxen / Naproxen Sodium | 845(E) / 15th June, 2005 |
| (v) | Norfloxacin | 846(E) / 15th June, 2005 |
(K. K. Jain)
Director (M&S)
Last Page Updated: 06-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)